Table 3_Therapeutic impact of Mongolian Andai therapy on gut microbiota and metabolomic pr

Table 3_Therapeutic impact of Mongolian Andai therapy on gut microbiota and metabolomic profiles in depression.xlsx contains results from a clinical study exploring a complementary depression treatment. The dataset, authored by Qila Sa and last updated in June 2026, likely contains tabular results from 16S rRNA sequencing and metabolomic analysis of 20 patients over 8 weeks. It includes findings on microbial taxa changes and metabolic pathway alterations linked to treatment response.

Use Cases

• Analyze changes in gut microbial composition based on 16S rRNA sequencing data mentioned in the description
• Investigate alterations in pyrimidine and purine metabolism pathways based on metabolomic analysis results
• Explore microbial-metabolite associations linked to therapeutic efficacy for depression as described in the integrated analysis
• Compare gut microbiota profiles, such as Proteobacteria and Bacteroidota levels, between patient groups before and after therapy

Strengths

• Dataset is licensed under CC-BY-4.0, allowing for open reuse and sharing
• Study design includes integrated multi-omics analysis (16S rRNA sequencing and metabolomics) on a defined cohort of 20 patients
• Bioinformatic analyses performed include PCA and KEGG enrichment, as stated in the methods

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download
• The dataset is very small at 25.0 KB, indicating limited scope

Provenance

Source

Qila Sa

Collection Method

Gut microbiota analyzed using 16S rRNA sequencing, and blood metabolites analyzed through metabolomics from a cohort of 20 depressed patients undergoing 8 weeks of Andai therapy.

Time Range

Study period not specified; data reflects an 8-week intervention.

Freshness

Last updated 2026-06-03 04:47:24; freshness should be verified